Preventive treatment for peanut allergies succeeds in study

February 20, 2018 by Marilynn Marchione
Preventive treatment for peanut allergies succeeds in study
This Feb. 20, 2015 file photo, photo shows an arrangement of peanuts in New York. The first treatment to help prevent serious allergic reactions to peanuts may be on the way. A company said Tuesday, Feb. 20, 2018 that its daily capsules of peanut flour helped sensitize children to nuts in a major study. (AP Photo/Patrick Sison, File)

The first treatment to help prevent serious allergic reactions to peanuts may be on the way. A company said Tuesday that its daily capsules of peanut powder helped children build tolerance in a major study.

Millions of children are allergic to peanuts, and some may have life-threatening reactions if accidentally exposed to them. Doctors have been testing daily doses of peanut, contained in a capsule and sprinkled over food, as a way to prevent that by gradually getting them used to very small amounts.

California-based Aimmune Therapeutics said 67 percent of kids who had its experimental treatment were able to tolerate the equivalent of roughly two peanuts at the end of the study, compared to only 4 percent of others given a dummy powder.

But a big warning: Don't try this at home.

"It's potentially dangerous," said Dr. Stacie Jones, a University of Arkansas allergy specialist. "This is investigational. It has to be done in a very safe setting" to make sure kids can be treated fast for any bad reactions that occur, she said.

Jones helped lead the study, consults for the company, and will give the results at an allergy conference next month. The results have not yet been reviewed by independent experts.

The study involved nearly 500 kids ages 4 to 17 with allergies so severe that they had reactions to as little as a tenth of a peanut. They were given either capsules of peanut or a dummy powder in gradually increasing amounts for six months, then continued on that final level for another six months. Neither the participants nor their doctors knew who was getting what until the study ended.

About 20 percent of kids getting the peanut powder dropped out of the study, 12 percent due to reactions or other problems. The product showed "overall good safety," Jones said.

"It's exciting," said Dr. Stacy Dorris of Vanderbilt University who had no role in the study.

"This is a way to potentially protect people who are allergic from having a severe or even fatal reaction. But it's not a cure ... we don't know what would happen if they stop or discontinue" treatment, she said.

Dorris said she would consider trying it for her 8-year-old daughter who has a peanut allergy, but said the study's drop-out rate shows that "this is not for everybody. Some people are going to have too many side effects for them to be able to take this daily dose."

Dr. Andrew Bird, an allergy specialist at UT Southwestern Medical Center in Dallas, also consults for the company and had patients in the study. The treatment doesn't allow kids to eat peanuts as if they had no allergy, but research suggests that being able to tolerate at least one peanut should protect 95 percent of them from having a reaction if they are exposed to peanuts, he said.

That would be a relief to Cathy Heald, a Dallas mom whose 10-year-old son, Charlie, was in the study.

"We had to teach him that he has to ask about everything he eats from a very early age," she said. "He's described it as living in a cage, watching other people get to eat what they want."

Charlie was assigned to the group given fake peanut powder but has been able to get the real thing since the study ended, she said.

Aimmune plans to seek U.S. Food and Drug Administration approval for the treatment later this year and in Europe early next year.

The company's chief executive has said he expects the first six months of treatment to cost $5,000 to $10,000, and $300 to $400 a month after that.

The thinking about peanut allergies has changed in recent years, and experts now think early exposure helps prevent them from forming. Last year, the National Institutes of Health issued new advice, saying most babies should get peanut-containing foods starting around 6 months, in age-appropriate forms like watered-down peanut butter or peanut puffs—not whole peanuts because those are a choking hazard.

Explore further: Reducing peanut allergy risks in children—The Nurse Practitioner presents update

Related Stories

Reducing peanut allergy risks in children—The Nurse Practitioner presents update

February 15, 2018
New prevention and treatment approaches can reduce serious health risks due to peanut allergy in children, according to an article in the March issue of The Nurse Practitioner.

Experimental peanut allergy patch shows promise

November 15, 2017
An experimental patch that delivers a high dose of peanut protein has shown promise in reducing allergic reactions in children and adults, researchers said on Tuesday.

New study suggests 21 percent increase in childhood peanut allergy since 2010

October 27, 2017
Parents often worry about peanut allergies because the reaction to peanuts can be very severe. New late-breaking research being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific ...

Study suggests women eating peanuts during breastfeeding could prevent child from developing allergy

October 2, 2017
(Medical Xpress)—A team of researchers with members from several institutions in Canada has conducted a study on women eating peanuts while breastfeeding and has found evidence that suggests doing so can reduce the chances ...

Video: Why are people allergic to peanuts?

March 22, 2016
For 1 to 2 percent of the global population, eating a peanut butter and jelly sandwich could be potentially fatal. What makes peanut allergies so lethal, and why is the number of peanut-allergy sufferers on the rise?

Recommended for you

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

PeterPassword
not rated yet Mar 06, 2018
The reason for the rise and rise of those allergic to peanuts swuggests some kind of change as a causative. Otherwise, why was it not even imagined years before it suddenly appeared?
I believe the reason was discovered by my wife, who pointed out that the 'allergy' appeared some time after nipple cream, sold for women to apply to sore nipples, made sore by too enthusiastic breast feeding, had peanut oil added to it. My wife was a keen reader of contents.
Babies breast feeding are far too young to meet substances that might challenge their undeveloped immune system. In normal life, they wouldn't encounter nuts until they had teeth and were eating solid food. Giving a tiny infant with a weak immune system peanut oil by way of the nipple is surely the most dangerous thing to do? Has anyone thought to carry out surveys on nipple cream usage compared with nut allergy to explore any links? Of course not, all research is directed elsewhere than to a likely cause.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.